Supplementary Table 1.
CRC Screening During COVID-19 Pandemic Among Adults Aged 50–75 Years, National Health Interview Survey 2021
| Up-to-date screening, % (95% CI) | Past-year CRC screening (CRC screening within 12 mo, % [95% CI]) |
|||||
|---|---|---|---|---|---|---|
| Any tests | Invasivea | Noninvasivea | Colonoscopy | FIT | ||
| Had COVID-19 infection | ||||||
| Yes (11.3%) | 69.3 (66.1–72.5) | 25.0 (22.2–27.9) | 16.0 (13.6–18.4) | 12.1 (9.8–14.3) | 15.6 (13.2–18.0) | 9.4 (7.3–11.5) |
| No (88.7%) | 71.3 (70.3–72.3) | 23.8 (22.8–24.8) | 13.5 (12.7–14.2) | 12.7 (11.9–13.6) | 13.2 (12.4–13.9) | 10.1 (9.4–10.9) |
| Had delayed care because of COVID-19 | ||||||
| Yes (21.8%) | 75.4 (73.5–77.4) | 26.2 (24.2–28.1) | 14.6 (13.1–16.1) | 14.4 (12.8–16.0) | 14.4 (12.9–15.9) | 11.8 (10.3–13.3) |
| No (78.2%) | 69.9 (68.7–71.0) | 23.3 (22.2–24.3) | 13.5 (12.7–14.4) | 12.2 (11.3–13.0) | 13.2 (12.4–14.0) | 9.5 (8.8–10.3) |
| Received COVID-19 vaccinationb | ||||||
| Yes (80.9%) | 75.1 (73.9–76.3) | 25.6 (24.3–26.8) | 14.7 (13.8–15.6) | 13.6 (12.6–14.6) | 14.4 (13.5–15.3) | 10.7 (9.8–11.6) |
| No (19.1%) | 53.7 (50.9–56.4) | 18.6 (16.4–20.7) | 10.0 (8.3–11.7) | 10.4 (8.7–12.0) | 9.6 (8.0–11.2) | 8.2 (6.8–9.7) |
CI, confidence interval; COVID-19, coronavirus disease 2019; CRC, colorectal cancer; CT, computed tomography; FIT, fecal immunochemical test.
a
Invasive studies include colonoscopy and flexible sigmoidoscopy. Noninvasive studies include FIT, FIT-DNA, and CT colonography.
b
Limit to second to fourth quarter of 2021 when COVID-19 vaccination information is available in National Health Interview Survey.